Medical AICited, interpretable calculators relevant to gastroenterology. Each tool shows its formula, how to measure every input, the interpretation bands, and the sources it stands on. Editorial navigation, not medical advice.
A non-invasive index using AST (relative to its upper limit of normal) and platelet count to estimate liver fibrosis. WHO hepatitis B guidance uses APRI greater than 2 to identify cirrhosis in adults in resource-limited settings; lower cutoffs (around 0.5 and 1.5) are used to rule out or rule in significant fibrosis, with the usual sensitivity and specificity trade-offs.
A simple 5-point score (0 to 5) for early risk stratification in acute pancreatitis, predicting in-hospital mortality within the first 24 hours. Each criterion scores 1 point. A score of 3 or more identifies substantially higher mortality and organ-failure risk.
The Child-Pugh score grades cirrhosis severity from five variables (bilirubin, albumin, INR, ascites, and encephalopathy), each scored 1 to 3. The total of 5 to 15 maps to Class A, B, or C, which correlates with survival and surgical risk and is still widely used in hepatology.
A non-invasive index combining age, AST, ALT, and platelet count to estimate the likelihood of advanced hepatic fibrosis, widely used as the first step in triaging chronic liver disease before elastography or biopsy.
A pre-endoscopy score (0 to 23) using blood urea, haemoglobin, systolic blood pressure, pulse, and clinical features to predict the need for intervention (transfusion, endoscopic therapy, or surgery) in acute upper gastrointestinal bleeding. A score of 0 (some use up to 1) identifies very-low-risk patients who may be considered for outpatient management.
The Maddrey discriminant function (mDF) grades the severity of alcohol-associated hepatitis from the prothrombin time prolongation and total bilirubin. A value of 32 or above identifies severe disease with high short-term mortality and is the classic threshold for considering corticosteroid therapy.
MELD-Na adds serum sodium to the classic MELD model (bilirubin, INR, creatinine), capturing the prognostic weight of hyponatraemia in cirrhosis. It estimates 90-day mortality and was used by OPTN for liver allocation from 2016 until MELD 3.0 superseded it.
Calculators give a number. When the patient in front of you needs the reasoning behind it, with the sources, the product does the looking-up.
Medical AI returns evidence-grounded answers backed by real citations. It is a reference tool, and these terms describe how it should and should not be used.
Medical AI is an information and reference tool intended for educational use only. The answers it returns are not medical advice, diagnosis, or treatment. Always consult a qualified doctor or healthcare professional with any question concerning a medical condition.
Medical AI is designed for use by practicing clinicians. It is not intended for direct patient use and is not a substitute for professional clinical judgment. Apply your own training and current guidelines to every decision an answer informs.
We do not collect, store, or process personally identifiable patient information (PHI or PII). Do not enter names, dates of birth, medical record numbers, or any other patient identifiers into the composer.
Medical knowledge evolves rapidly. Citations carry their publication date, so consult the primary source and the most recent clinical guideline before acting on anything material.